Level Bio AB logo

Level Bio AB (LEVBIO)

Market Closed
7 Aug, 15:25
XSTO XSTO
kr
0. 23
-0.01
-4.1667%
kr
20.29M Market Cap
- P/E Ratio
- Div Yield
25,000 Volume
- Eps
kr 0.24
Previous Close
Add Transaction
Day Range
0.23 0.23
Year Range
0 0
Want to track LEVBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LEVBIO closed Friday lower at kr0.23, a decrease of -4.1667% from Thursday's close, completing a monthly increase of 0% or kr0.23. Over the past 12 months, LEVBIO stock gained 0%.
LEVBIO is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

LEVBIO Chart

People also search for

Abas Protect AB
kr 7.35
+1.3793%
Lyckegard Group AB
kr 2.92
+1.3889%
Hexicon AB
kr 0.12
+0.8097%
Railway Metrics and Dynamics
kr 1.11
+1.3699%
Sonetel AB
kr 5.8
+0.346%

Level Bio AB (LEVBIO) FAQ

What is the stock price today?

The current price is kr0.23.

On which exchange is it traded?

Level Bio AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is LEVBIO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 20.29M.

Has Level Bio AB ever had a stock split?

No, there has never been a stock split.

Level Bio AB Profile

Professional Services Industry
Industrials Sector
Mr. Mikael Havsjo CEO
XSTO Exchange
- ISIN
SE Country
13 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Level Bio AB (publ), initially known as AlphaHelix Molecular Diagnostics AB, stands as a formidable entity in the design, development, and distribution of diagnostic products, reaching the Nordic region and beyond. Since its inception in 1998 and subsequent rebranding in May 2024, the company has established its headquarters in Stockholm, Sweden. It focuses on an array of diagnostics areas including genetic fetal diagnostics, genetic miscarriage, infertility diagnostics products, and the development of products targeting congenital heart defect. By catering to the Nordic region, specifically Sweden, and other international markets, Level Bio AB (publ) ensures the provision of top-tier equipment, consumables, reagents for molecular biology, and both research and diagnostic products.

Products and Services

  • Rob: An automated 96/384 qPCR setup that revolutionizes quantitative PCR by offering automation, thus enhancing the efficiency and accuracy of gene quantitation. Rob's design caters to high-throughput requirements while ensuring precise and reliable results, making it a cornerstone for researchers and pathologists alike.
  • BugScreener: Dedicated to combating antibiotic resistance, this advanced system is designed for the screening of methicillin-resistant Staphylococcus aureus (MRSA). BugScreener simplifies and accelerates the detection process of this dangerous pathogen, thereby facilitating more timely and appropriate interventions.
  • aAmp: A pioneering thermal cycler that employs SuperConvection technology to provide unparalleled accuracy in PCR assays. This technology ensures rapid thermal ramping and precise temperature control, which are crucial for the amplification and study of DNA sequences. aAmp stands as a testament to Level Bio AB's commitment to innovation and excellence in genetic analysis.

Contact Information

Address: Västra Finnbodavägen 4B
Phone: 46 86 26 76 00